- Conditions
- Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, +135 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- University of Torino Torino, Italy
Clinical trial condition
Adult Nasal Type Extranodal NK/T-cell Lymphoma
Explore clinical trials studying Adult Nasal Type Extranodal NK/T-cell Lymphoma. Study availability and eligibility vary by location and protocol.
51 public trials
0 recruiting studies
Adult Nasal Type Extranodal NK/T-cell Lymphoma trial results
NCT00601718
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +83 more
- Locations
-
- Puget Sound Oncology Consortium Seattle, Washington, United States
NCT01110135
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +80 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00112593
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +281 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01427881
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +138 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer
NCT00049504
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +160 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
NCT01466881
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +23 more
- Locations
-
- Providence Hospital Mobile, Alabama, United States
- The University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
- The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
Completed
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
NCT01748721
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +103 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Children's Hospital of Orange County Orange, California, United States
- University of California San Francisco Medical Center - Parnassus San Francisco, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
NCT01658319
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +85 more
- Locations
-
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT01959477
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +202 more
- Locations
-
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States